Richard Pulik - 21 Apr 2025 Form 4 Insider Report for Roivant Sciences Ltd. (ROIV)

Role
CFO
Signature
By: /s/ Jo Chen, as Attorney-in-Fact for Richard Pulik
Issuer symbol
ROIV
Transactions as of
21 Apr 2025
Net transactions value
$0
Form type
4
Filing time
23 Apr 2025, 21:00:21 UTC
Previous filing
01 Apr 2025
Next filing
30 Apr 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ROIV Common Shares Award $0 +141,464 +53% $0.000000 407,352 21 Apr 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ROIV Stock Option (Right to Buy) Award $0 +180,413 $0.000000 180,413 21 Apr 2025 Common Shares 180,413 $10.04 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects an award of restricted stock units with respect to Common Shares ("RSUs") with a vesting commencement date of April 20, 2025. These RSUs service-vest as follows: (i) 25% on the date thirteen (13) months from the vesting commencement date; and (ii) in twelve (12) successive equal quarterly installments thereafter, measured from the date thirteen (13) months from the vesting commencement date, subject to the reporting person's continuous service through the applicable vesting date.
F2 Reflects an award of stock options to purchase Common Shares with a vesting commencement date of April 20, 2025. These options vest and become exercisable as follows: (i) 25% on the first anniversary of the vesting commencement date; and (ii) in thirty-six (36) successive equal monthly installments thereafter, measured from the first anniversary of the vesting commencement date, subject to the reporting person's continuous service through the applicable vesting date.